Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TSAT | AAOI |
|---|---|---|
| Price | $46.74 | $122.54 |
| Change today | ▼ 1.93% | ▼ 5.85% |
| Market cap | $711.35M | $10.40B |
| Return, 3 months | +10.1% | +0.3% |
| Return, year to date | +60.6% | +251.5% |
| Return, 1 year | +36.0% | +280.3% |
| P/E (TTM) | -2.6 | -159.1 |
| P/B | 2.7 | 6.2 |
| P/E percentile vs own 5y | 47th | 7th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -25.1% | +86.4% |
| Net profit growth (YoY) | -839.5% | -150.4% |
| Gross margin | 92.9% | 28.9% |
| Operating margin | 0.1% | -10.6% |
| Net margin | -102.9% | -9.6% |
| Return on equity | -70.7% | -5.4% |
| Analyst target vs. price | +40.5% | +39.1% |
| Analyst buy share | 60% | 75% |
| RSI (14) | 49 | 59 |
| 30-day volatility | 57.5% | 72.7% |
| Max drawdown, 1 year | -41.2% | -65.7% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
